Table 2: Intensive care-related risk factors of adverse outcome early after ICU discharge.
Factor | Group A (n = 13) | Group B (n = 11) | Group C (n = 130) | p-value |
ICU LOS (days) | 13 (7-26) | 21 (14-34) | 11 (6-19) | 0.061 |
Length of CVC (days) | 13 (7-33) | 21 (14-35) | 11 (6-21) | 0.068 |
Length of MV (days) | 8 (4-12) | 13 (5-26) | 7 (3-13) | 0.324 |
Length of norepinephrine support (days) | 5 (4-15) | 15 (2-21)* | 3 (0-8) | 0.012 |
CVVHDF | 3 (23.1) | 1 (9.1) | 15 (11.5) | 0.456 |
Tracheostomya | 3 (23.1) | 3 (27.3) | 21 (16.1) | 0.557 |
CVCa | 13 (100) | 11 (100) | 112 (86.1) | 0.152 |
Nasogastric tubea | 8 (61.5) | 8 (72.7) | 58 (44.6) | 0.120 |
Colonization with MDR pathogena | 9 (69.2) | 7 (63.6) | 60 (46.1) | 0.175 |
Weekday dischargea | 11 (84.6) | 11 (100) | 115 (88.4) | 0.439 |
Morning shift dischargea | 10 (76.9) | 10 (90.1) | 100 (76.9) | 0.560 |
In hospital discharge | 10 (76.9) | 6 (54.5) | 86 (66.1) | 0.513 |
*Significantly different compared to Group C; Data are no. (%) of patients or median (IQR).
LOS: Length of Stay; CVC: Central Venous Catheter; MV: Mechanical Ventilation; CVVHDF: Continuous Veno-Venous Hemodiafiltration; MDR: Multidrug-Resistant; IQR: Interquartile Range.
aAt ICU discharge.